Breaking News Instant updates and real-time market news.

VCYT

Veracyte

$7.73

-0.04 (-0.51%)

13:58
02/17/17
02/17
13:58
02/17/17
13:58

Veracyte strength attributed to revised BCBS of Tenn. policy draft

The move higher in shares of Veracyte is being attributed to a draft of a revised policy from BlueCross BlueShield of Tennessee. The draft, which states "Do Not Implement" at the top, shows changes that read, "Testing of molecular markers in fine-needle aspirates of the thyroid is considered medically necessary if appropriateness criteria are met." Veracyte makes Afirma Thyroid. Reference Link

  • 01

    Mar

VCYT Veracyte
$7.73

-0.04 (-0.51%)

11/29/16
JANY
11/29/16
UPGRADE
JANY
Buy
Veracyte upgraded to Buy from Neutral at Janney Capital
11/29/16
JANY
11/29/16
UPGRADE
JANY
Buy
Veracyte upgraded at Janney Capital
As noted earlier, Janney Capital upgraded Veracyte to Buy from Neutral. Analyst Paul Knight says that the company's "disciplined test development, commercialization, and reimbursement processes" insulate it from a number of problems plaguing the pharma sector. He thinks that recent regulatory changes have "dramatically reduced" the company's pricing risk. Target to $16 from $8.
11/29/16
11/29/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pfizer (PFE) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying he sees a greater likelihood that Pfizer will be able to access its cash overseas under the new administration, which could be used to acquire growth assets and return capital to shareholders. 2. Comerica (CMA) upgraded to Outperform from Market Perform at Keefe Bruyette. 3. Tractor Supply (TSCO) upgraded to Buy from Neutral at Northcoast with analyst Chuck Cerankosky saying he expects the company to benefit from colder weather and the improving US economy and said product assortments and promotions have also been adjusted to the new economics of the energy patch and its impact on this company's customers. 4. Del Frisco's (DFRG) upgraded to Outperform from Neutral at Credit Suisse with analyst Jason West saying it is a key beneficiary of improved high-end consumer and corporate spending. 5. Veracyte upgraded to Buy from Neutral at Janney Capital with analyst Paul Knight saying the company's "disciplined test development, commercialization, and reimbursement processes" insulate it from a number of problems plaguing the pharma sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/08/17
CANT
02/08/17
NO CHANGE
Target $13
CANT
Overweight
Veracyte pact with Quest should improve Afirma reimbursement, says Cantor
Cantor Fitzgerald analyst Bryan Brokmeier believes Veracyte's (VCYT) agreement with Quest Diagnostics (DGX) for its Afirma Gene Expression Classifier expands access which, in addition to accelerating growth, should improve reimbursement rate and margins. Other diagnostic partners have said that Quest has become more of a driver of sales of proprietary tests, particularly for higher value tests, which leaves Brokmeier encouraged that the partnership will pay off for Veracyte, he tells investors. The analyst reiterates an Overweight rating and $13 price target on Veracyte shares following the news.

TODAY'S FREE FLY STORIES

TWTR

Twitter

$20.13

-0.4 (-1.95%)

14:50
07/21/17
07/21
14:50
07/21/17
14:50
Options
Defensive option play in Twitter ahead of earnings next week »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

  • 13

    Sep

GS

Goldman Sachs

$220.60

-1.7 (-0.76%)

14:47
07/21/17
07/21
14:47
07/21/17
14:47
Conference/Events
Goldman Sachs to hold a conference call »

EVP & CFO Chavez and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 17

    Oct

RL

Ralph Lauren

$74.91

1.15 (1.56%)

14:45
07/21/17
07/21
14:45
07/21/17
14:45
Options
Ralph Lauren call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 10

    Aug

WHLR

Wheeler REIT

$11.01

0.28 (2.61%)

14:41
07/21/17
07/21
14:41
07/21/17
14:41
Hot Stocks
NS Advisors reports 5.4% stake in Wheeler REIT »

Recently, NS Advisors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

BKJ

Bancorp of New Jersey

$16.80

-0.2 (-1.18%)

14:30
07/21/17
07/21
14:30
07/21/17
14:30
Hot Stocks
Breaking Hot Stocks news story on Bancorp of New Jersey »

Clover Partners reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMPH

Amphastar

$17.92

0.18 (1.01%)

, MNTA

Momenta

$17.25

0.35 (2.07%)

14:29
07/21/17
07/21
14:29
07/21/17
14:29
Recommendations
Amphastar, Momenta, Novartis analyst commentary  »

Amphastar…

AMPH

Amphastar

$17.92

0.18 (1.01%)

MNTA

Momenta

$17.25

0.35 (2.07%)

NVS

Novartis

$84.78

-0.64 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 17

    May

MNTA

Momenta

$17.25

0.35 (2.07%)

14:22
07/21/17
07/21
14:22
07/21/17
14:22
Hot Stocks
Momenta: Jury finds patent on Lovenox manufacturing infringed but invalid »

Momenta Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

WLL

Whiting Petroleum

$5.02

-0.0951 (-1.86%)

14:20
07/21/17
07/21
14:20
07/21/17
14:20
Options
Second day of interest in Whiting Petroleum Jan 8 calls »

Second day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

$NSD

NASDAQ Market Internals

14:17
07/21/17
07/21
14:17
07/21/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
07/21/17
07/21
14:16
07/21/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAST

Fastenal

$43.07

0.39 (0.91%)

14:15
07/21/17
07/21
14:15
07/21/17
14:15
Options
Fastenal put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
07/21/17
07/21
14:15
07/21/17
14:15
General news
Treasury Action: supply complicates trading in the coming week »

Treasury Action: supply…

14:10
07/21/17
07/21
14:10
07/21/17
14:10
General news
NY Fed's overnight reverse repo totaled $122.7 B, with 37 counterparties »

NY Fed's overnight…

IWM

iShares Trust Russell 2000 Index Fund

$142.55

-0.65 (-0.45%)

, RUT

Russell 2000 Index

14:08
07/21/17
07/21
14:08
07/21/17
14:08
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT)…

IWM

iShares Trust Russell 2000 Index Fund

$142.55

-0.65 (-0.45%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$246.68

-0.42 (-0.17%)

, SPX

S&P 500

14:07
07/21/17
07/21
14:07
07/21/17
14:07
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX)…

SPY

SPDR S&P 500 ETF Trust

$246.68

-0.42 (-0.17%)

SPX

S&P 500

AAPL

Apple

$150.34

-0.68 (-0.45%)

IBM

IBM

$146.68

-0.98 (-0.66%)

XLK

Technology Select Sector SPDR

$57.38

-0.16 (-0.28%)

XLU

Utilities SPDR

$52.98

0.065 (0.12%)

XLV

Health Care Select Sector SPDR

$81.00

-0.08 (-0.10%)

XLP

Consumer Staples Sector SPDR

$54.98

-0.01 (-0.02%)

XLE

Energy Select Sector SPDR

$65.26

-0.5 (-0.76%)

XLF

Financial Select Sector

$24.85

0.05 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

14:05
07/21/17
07/21
14:05
07/21/17
14:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY posted…

ECA

Encana

$9.95

0.28 (2.90%)

14:00
07/21/17
07/21
14:00
07/21/17
14:00
Options
Encana with a large call ratio spread as a bullish play is adjusted »

Encana with a large call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

TJX

TJX

$68.63

-0.97 (-1.39%)

13:55
07/21/17
07/21
13:55
07/21/17
13:55
Options
TJX put volume heavy and directionally bearish »

Bearish flow noted in TJX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$8.50

0.12 (1.43%)

, SFTBF

SoftBank

$83.15

-0.02 (-0.02%)

13:53
07/21/17
07/21
13:53
07/21/17
13:53
Periodicals
Sprint enters into partnership talks with Comcast, Charter, Nikkei reports »

SoftBank (SFTBF)…

S

Sprint

$8.50

0.12 (1.43%)

SFTBF

SoftBank

$83.15

-0.02 (-0.02%)

CMCSA

Comcast

$39.49

0.15 (0.38%)

CMCSK

Comcast

TMUS

T-Mobile

$61.12

-0.85 (-1.37%)

CHTR

Charter

$345.30

-1.31 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 27

    Jul

  • 01

    Aug

  • 03

    Aug

  • 08

    Aug

  • 14

    Aug

BTG

B2Gold

$2.75

0.04 (1.48%)

13:40
07/21/17
07/21
13:40
07/21/17
13:40
Options
In the money call write in B2Gold »

In the money call write…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPB

Mid Penn Bancorp

$26.30

-0.2 (-0.75%)

13:37
07/21/17
07/21
13:37
07/21/17
13:37
Hot Stocks
Mid Penn Bancorp receives regulatory clearance to open Halifax branch »

Mid Penn Bank, subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRG

NRG Energy

$24.20

0.089 (0.37%)

13:30
07/21/17
07/21
13:30
07/21/17
13:30
Options
Notable new position opened in NRG options »

Notable new position…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

13:30
07/21/17
07/21
13:30
07/21/17
13:30
General news
Action Economics Survey results: »

Action Economics Survey…

HAIN

Hain Celestial

$42.79

1.05 (2.52%)

13:23
07/21/17
07/21
13:23
07/21/17
13:23
Conference/Events
Hain Celestial management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

VIX

Volatility Index S&P 500 Options

13:20
07/21/17
07/21
13:20
07/21/17
13:20
Options
Impressive 3-way boosts VIX option volume by a million contracts »

Impressive 3-way boosts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.